Pratap, D. V. S., Philip, M., Rao, N. T., Jerajani, H. R., Kumar, S. A., Kuruvila, M., . . . Dhawan, S. (2013). Evaluation of Efficacy, Safety, and Tolerability of Fixed Dose Combination (FDC) of Halometasone 0.05% and Fusidic Acid 2% W/W Topical Cream Versus FDC of Betamethasone Valerate 0.12% and Neomycin Sulphate 0.5% W/W Topical Cream in the Treatment of Infected Eczematous Dermatosis in Indian Subjects: A Randomized Open-Label Comparative Phase III Multi-Centric Trial. Medknow Publications & Media Pvt Ltd.

Pratap, Dasiga Venkata Subrahmanya, Mariam Philip, Narayana T. Rao, Hemangi R. Jerajani, Sainath A. Kumar, Maria Kuruvila, Latha S. Moodahadu, a Shilpi Dhawan. Evaluation of Efficacy, Safety, and Tolerability of Fixed Dose Combination (FDC) of Halometasone 0.05% and Fusidic Acid 2% W/W Topical Cream Versus FDC of Betamethasone Valerate 0.12% and Neomycin Sulphate 0.5% W/W Topical Cream in the Treatment of Infected Eczematous Dermatosis in Indian Subjects: A Randomized Open-Label Comparative Phase III Multi-Centric Trial. Medknow Publications & Media Pvt Ltd, 2013.

Pratap, Dasiga Venkata Subrahmanya, et al. Evaluation of Efficacy, Safety, and Tolerability of Fixed Dose Combination (FDC) of Halometasone 0.05% and Fusidic Acid 2% W/W Topical Cream Versus FDC of Betamethasone Valerate 0.12% and Neomycin Sulphate 0.5% W/W Topical Cream in the Treatment of Infected Eczematous Dermatosis in Indian Subjects: A Randomized Open-Label Comparative Phase III Multi-Centric Trial. Medknow Publications & Media Pvt Ltd, 2013.